Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to Ferrone, Soldano
Item TypeName
Academic Article International Conference on the Biology of Melanoma. Aviano, Italy, 24-26 September 1995.
Academic Article Tumors as elusive targets of T-cell-based active immunotherapy.
Academic Article Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck.
Academic Article Immunotherapy of melanoma targeting human high molecular weight melanoma-associated antigen: potential role of nonimmunological mechanisms.
Academic Article Monoclonal antibodies and tumor vaccines.
Academic Article HLA class I antigen loss, tumor immune escape and immune selection.
Academic Article Immunotherapy dispenses with tumor antigens.
Academic Article Mouse dendritic-endothelial cell hybrids and 4-1BB costimulation elicit antitumor effects mediated by broad antiangiogenic immunity.
Academic Article Selective histocompatibility leukocyte antigen (HLA)-A2 loss caused by aberrant pre-mRNA splicing in 624MEL28 melanoma cells.
Academic Article Molecular and functional phenotypes of melanoma cells with abnormalities in HLA class I antigen expression.
Academic Article Active specific immunotherapy of malignant melanoma and peptide mimics of the human high-molecular-weight melanoma-associated antigen.
Academic Article Tumor antigen-targeted, monoclonal antibody-based immunotherapy: clinical response, cellular immunity, and immunoescape.
Academic Article Chordoma and chondrosarcoma gene profile: implications for immunotherapy.
Academic Article Cytoplasmic melanoma-associated antigen (CYT-MAA) serum level in patients with melanoma: a potential marker of response to immunotherapy?
Academic Article Immunotherapy of malignant diseases. Challenges and strategies.
Academic Article Immune selection of hot-spot beta 2-microglobulin gene mutations, HLA-A2 allospecificity loss, and antigen-processing machinery component down-regulation in melanoma cells derived from recurrent metastases following immunotherapy.
Academic Article Hidden immunotherapy targets challenge dogma.
Academic Article Presence and prognostic significance of melanoma-associated antigens CYT-MAA and HMW-MAA in serum of patients with melanoma.
Academic Article Soluble human leukocyte antigen--G serum level is elevated in melanoma patients and is further increased by interferon-alpha immunotherapy.
Academic Article DNA vaccine expressing the mimotope of GD2 ganglioside induces protective GD2 cross-reactive antibody responses.
Academic Article Human tumor associated antigen mimicry by xenoantigens, anti-idiotypic antibodies and peptide mimics: implications for immunotherapy of malignant diseases.
Academic Article Immunotherapeutic approach to rheumatoid arthritis with anti-idiotypic antibodies to HLA-DR4.
Academic Article Immunogenicity of human neuroblastoma.
Academic Article NY-BR-1 protein expression in breast carcinoma: a mammary gland differentiation antigen as target for cancer immunotherapy.
Academic Article Cancer immunotherapy targeting the high molecular weight melanoma-associated antigen protein results in a broad antitumor response and reduction of pericytes in the tumor vasculature.
Academic Article HLA antigen changes in malignant cells: epigenetic mechanisms and biologic significance.
Academic Article Immunotherapy of cancer in 2012.
Academic Article Escape of human solid tumors from T-cell recognition: molecular mechanisms and functional significance.
Academic Article Can combined T-cell- and antibody-based immunotherapy outsmart tumor cells?
Academic Article Where have all the T cells gone? Mechanisms of immune evasion by tumors.
Academic Article Active specific immunotherapy with antiidiotypic antibodies in patients with solid tumors.
Academic Article HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story.
Academic Article Targeting ALDH(bright) human carcinoma-initiating cells with ALDH1A1-specific CD8? T cells.
Academic Article Immunotherapy of malignant disease with tumor antigen-specific monoclonal antibodies.
Academic Article Anti-tyrosinase antibodies participate in the immune response to vaccination with anti-idiotypic antibodies mimicking the high-molecular-weight melanoma-associated antigen.
Academic Article Targeting 11q23 positive acute leukemia cells with high molecular weight-melanoma associated antigen-specific monoclonal antibodies.
Academic Article NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo.
Academic Article Functional and clinical relevance of chondroitin sulfate proteoglycan 4.
Academic Article CSPG4 in cancer: multiple roles.
Academic Article A single chain immunotoxin, targeting the melanoma-associated chondroitin sulfate proteoglycan, is a potent inducer of apoptosis in cultured human melanoma cells.
Academic Article Monoclonal antibodies for cancer immunotherapy.
Academic Article T-cell-based immunotherapy of melanoma: what have we learned and how can we improve?
Academic Article Association between induction of anti high molecular weight-melanoma associated antigen (HMW-MAA) immunity with mouse antiidiotypic monoclonal antibody (MoAb) MK2-23 and prolongation of survival in patients with melanoma.
Academic Article Immunotherapeutic approaches with monoclonal antibodies to immunological diseases.
Academic Article Immunotherapy of melanoma: the good news, the bad ones and what to do next.
Academic Article A high molecular weight melanoma-associated antigen-specific chimeric antigen receptor redirects lymphocytes to target human melanomas.
Academic Article New aspects in the treatment of immunomediated diseases.
Academic Article CSPG4 as a target of antibody-based immunotherapy for malignant mesothelioma.
Academic Article Cancer immunotherapy: Progress and challenges in the clinical setting.
Academic Article Peptides mimicking GD2 ganglioside elicit cellular, humoral and tumor-protective immune responses in mice.
Academic Article Human high molecular weight-melanoma associated antigen as a target for active specific immunotherapy--a phase I clinical trial with murine antiidiotypic monoclonal antibodies.
Academic Article Functional characterization of an scFv-Fc antibody that immunotherapeutically targets the common cancer cell surface proteoglycan CSPG4.
Academic Article CSPG4 protein as a new target for the antibody-based immunotherapy of triple-negative breast cancer.
Academic Article Melanoma, immune surveillance, and immunotherapy.
Academic Article Human tumor-associated antigen mimicry by anti-idiotypic antibodies. Immunogenicity and clinical trials in patients with solid tumors.
Academic Article Breast cancer cells expressing stem cell markers CD44+ CD24 lo are eliminated by Numb-1 peptide-activated T cells.
Academic Article IRX-2, a novel immunotherapeutic, enhances functions of human dendritic cells.
Academic Article Human high molecular weight melanoma-associated antigen mimicry by mouse antiidiotypic monoclonal antibody MK2-23. Characterization of the immunogenicity in syngeneic hosts.
Academic Article Sustained high levels of circulating chaperoned interleukin-6 after active specific cancer immunotherapy.
Academic Article Kinetics of the immune response and regression of metastatic lesions following development of humoral anti-high molecular weight-melanoma associated antigen immunity in three patients with advanced malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23.
Academic Article Anti-idiotypes in melanoma.
Academic Article Future perspectives in melanoma research. Meeting report from the "Melanoma research: a bridge from Naples to the World. Napoli, December 5th-6th 2011".
Academic Article Active specific immunotherapy of malignant melanoma with anti-idiotypic monoclonal antibodies.
Academic Article Immunotherapy of melanoma: peptide mimics of a human high molecular weight-melanoma associated antigen.
Academic Article Tumor associated antigen (TAA) mimicry and immunotherapy of malignant diseases from anti-idiotypic antibodies to peptide mimics.
Academic Article Molecular mechanisms of HLA class I antigen abnormalities following viral infection and transformation.
Academic Article Suppression of human melanoma growth in nude mice injected with anti high-molecular-weight melanoma-associated antigen monoclonal antibody 225.28S conjugated to purothionin.
Concept Immunotherapy, Active
Concept Immunotherapy, Adoptive
Concept Immunotherapy
Academic Article Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death.
Academic Article Multidisciplinary approach to patient with malignant melanoma.
Academic Article Emerging BRAF inhibitors for melanoma.
Academic Article Monoclonal antibody-based immunotherapy of ovarian cancer: targeting ovarian cancer cells with the B7-H3-specific mAb 376.96.
Academic Article Novel tumor antigen-specific monoclonal antibody-based immunotherapy to eradicate both differentiated cancer cells and cancer-initiating cells in solid tumors.
Academic Article Future perspectives in melanoma research: meeting report from the "Melanoma Bridge", Napoli, December 5th-8th 2013.
Academic Article Chondroitin sulfate proteoglycan 4 as a target for chimeric antigen receptor-based T-cell immunotherapy of solid tumors.
Academic Article Multiple structural and epigenetic defects in the human leukocyte antigen class I antigen presentation pathway in a recurrent metastatic melanoma following immunotherapy.
Academic Article Future perspectives in melanoma research: meeting report from the "Melanoma Bridge": Napoli, December 3rd-6th 2014.
Academic Article Intracellular antigens as targets for antibody based immunotherapy of malignant diseases.
Academic Article PD-L1 and HLA Class I Antigen Expression and Clinical Course of the Disease in Intrahepatic Cholangiocarcinoma.
Academic Article HLA class I downregulation is associated with enhanced NK-cell killing of melanoma cells with acquired drug resistance to BRAF inhibitors.
Grant IMMUNOTHERAPY OF MELANOMA WITH ANTIIDIOTYPIC ANTIBODIES
Grant HSP based combinatorial immunotherapy in triple negative breast cancer
Grant PEPTIDE MIMICS AND IMMUNOTHERAPY OF MELANOMA
Grant Combinatorial targeting of melanoma initiating cells
Grant Immune Escape in Human Cancer: Mechanisms and Therapeutic Implications
Grant BREAKING UNRESPONSIVENESS TO MAA WITH PETIDE MIMICS
Grant Rational Design of HMW-MAA Peptide Mimics
Grant HLA CLASS I PEPTIDE COMPLEX ADNORMALITIES IN MELANOMA
Academic Article Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.
Academic Article Immunomodulating and Immunoresistance Properties of Cancer-Initiating Cells: Implications for the Clinical Success of Immunotherapy.
Academic Article Innovative Therapy, Monoclonal Antibodies and Beyond.
Academic Article Future perspectives in melanoma research "Melanoma Bridge", Napoli, November 30th-3rd December 2016.
Academic Article Translational Research in Cutaneous Melanoma: New Therapeutic Perspectives.
Academic Article Constitutive and TNFa-inducible expression of chondroitin sulfate proteoglycan 4 in glioblastoma and neurospheres: Implications for CAR-T cell therapy.
Academic Article Methods for improving the immunogenicity and efficacy of cancer vaccines.
Academic Article Perspectives in melanoma: Meeting report from the Melanoma Bridge (30 November-2 December, 2017, Naples, Italy).
Grant IL-15 TRiKES-based specific immunotherapy of TNBC; resistance mechanisms
Grant IL-15 TRiKES-based specific immunotherapy of pancreatic ductal adenocarcinoma
Academic Article The role of cancer stem cells in the modulation of anti-tumor immune responses.
Academic Article Resistance to anti-PD-1-based immunotherapy in basal cell carcinoma: a case report and review of the literature.
Academic Article Addressing current challenges and future directions in immuno-oncology: expert perspectives from the 2017 NIBIT Foundation Think Tank, Siena, Italy.
Grant T cell plasticity, fusion proteins and CAR T cell-based immunotherapy of head and neck cancer
Academic Article Antitumor Responses in the Absence of Toxicity in Solid Tumors by Targeting B7-H3 via Chimeric Antigen Receptor T Cells.
Grant Adaptive immunotherapy of anaplastic thyroid cancer
Academic Article Perspectives in melanoma: meeting report from the Melanoma Bridge (November 29th-1 December 1st, 2018, Naples, Italy).
Academic Article CD16-158-valine chimeric receptor T cells overcome the resistance of KRAS-mutated colorectal carcinoma cells to cetuximab.
Academic Article B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheres.
Academic Article HLA Class I Antigen Processing Machinery Defects in Cancer Cells-Frequency, Functional Significance, and Clinical Relevance with Special Emphasis on Their Role in T Cell-Based Immunotherapy of Malignant Disease.
Academic Article Immunotherapeutics for head and neck squamous cell carcinoma stem cells.
Academic Article Targeting the innate immunoreceptor RIG-I overcomes melanoma-intrinsic resistance to T cell immunotherapy.
Search Criteria
  • Immunotherapy
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.